Long-acting rhG-CSF Market

Future Market Insights

Key Insight

The long-acting rhG-CSF market is projected to grow from USD 4.5 billion in 2025 to USD 8.2 billion by 2035, at a CAGR of 6.2%. Long-acting rhG-CSF will dominate with a 58.7% market share, while neoplastic diseases will lead the application segment with a 76.4% share.

November 06, 2025

Anurag Sharma

250 Pages

Cite this Report

Long-acting rhG-CSF Market

https://www.futuremarketinsights.com/reports/long-acting-rhg-csf-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Biocon Biologics Inc
Coherus BioSciences

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Long-acting rhG-CSF Market

Key Players

Similar Industry Reports